- ►diabetesjournals.org R Zimmermann, U Panzenböck, A Wintersperger, S … - Diabetes, 2001 - Am Diabetes Assoc The nonenzymatic glycation of LDL is a naturally occurring chemical modification of apolipoprotein
(apo)-B lysine residues by glucose. Once glycated, LDL is only poorly recognized by lipoprotein
receptors including the LDL receptor (LDL-R), the LDL-R–related protein (LRP), and ... Cited by 35 - Related articles - BL Direct - All 6 versions
FG Gbaguidi, G Chinetti, D Milosavljevic, E Teissier, J … - FEBS letters, 2002 - Elsevier Lipoprotein lipase (LPL) acts independently of its function as triglyceride hydrolase by stimulating
macrophage binding and uptake of native, oxidized and glycated LDL. Peroxisome
proliferator-activated receptors (PPARs) are nuclear receptors expressed in monocyte/ ... Cited by 57 - Related articles - All 6 versions
- ►jlr.org G Haraguchi, Y Kobayashi, ML Brown, A Tanaka, M … - The Journal of Lipid …, 2003 - ASBMB Certain triglyceride-rich lipoproteins (TRLs), specifically chylomicrons, dyslipemic VLDLs, and
their remnants, are atherogenic and can induce monocyte-macrophage foam cell formation in
vitro via the apolipoprotein B-48 receptor (apoB-48R). Human atherosclerotic lesion foam ... Cited by 36 - Related articles - BL Direct - All 4 versions
- ►jlr.org [PDF] G Renier, AC Desfaits, A Lambert, R Mikhail - The Journal of Lipid Research, 1996 - ASBMB Abstract We investigated, in the present study, the role of reactive oxygen intermediates
(ROI) in the control of macro- phage lipoprotein lipase (LPL) secretion. Exposure of murine macrophages
to increasing concentrations of hydrogen per- oxide (H202) resulted in enhanced basal ... Cited by 15 - Related articles - BL Direct - All 3 versions
MP Cohen, Y Jin, GT Lautenslager - Diabetes Technology & …, 2004 - liebertonline.com Nonenzymatic glycation of apolipoprotein B in the low-density lipoprotein (LDL) complex has
been considered a proatherogenic modification contributory to the increased suscepti- bility of
patients with diabetes to atherosclerosis. We postulated that glycated LDL concen- ... Cited by 7 - Related articles - BL Direct - All 3 versions
WF Graier, GM Kostner - European journal of clinical investigation, 1997 - ncbi.nlm.nih.gov 1: Eur J Clin Invest. 1997 Jun;27(6):457-9. Glycated low-density lipoprotein and
atherogenesis: the missing link between diabetes mellitus and hypercholesterolaemia?
Graier WF, Kostner GM. Publication Types: Editorial; Research ... Cited by 18 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org M Artwohl, WF Graier, M Roden, M Bischof, A … - Diabetes, 2003 - Am Diabetes Assoc This study compares the effects of LDL glycated either in vitro (LDL iv ) or in vivo in diabetic patients
(LDL D ) on apoptosis, proliferation, and associated protein expression in cultured human umbilical
vein endothelial cells. At 100 mg/l, both LDL species considerably increase apoptosis ... Cited by 36 - Related articles - BL Direct - All 4 versions
MCW Lam, KCB Tan, KSL Lam - Atherosclerosis, 2004 - Elsevier Low-density lipoprotein (LDL) in patients with diabetes is subject to modification by both oxidation
and glycation. In contrast to oxidized LDL, the biological effects of glycoxidized LDL have not
been well characterised. In this study, the effects of oxidized, glycated, glycoxidized and ... Cited by 23 - Related articles - All 16 versions
- ►jlr.org G Llaverias, M Vazquez-Carrera, RM Sanchez, V … - The Journal of Lipid …, 2004 - ASBMB Peroxisome proliferator-activated receptor (PPAR ) activation or overexpression induces
caveolin-1 (cav-1) expression in several cell types. The objective of this study was to investigate
if PPAR agonists could also regulate the cav-1 gene in macrophages and to explore the ... Cited by 25 - Related articles - BL Direct - All 4 versions
